Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03467009 · ClinicalTrials.gov registry record · NA
Bullying Prevention Intervention for Adolescent Primary Care Patients
A NA study, sponsored by Rhode Island Hospital.
- Completed
- Registry status
- NA
- Development phase
- 77
- Enrollment target
NCT03467009: Completed NA study, sponsored by Rhode Island Hospital.
NCT03467009 is a NA study that has completed, run by Rhode Island Hospital. The registered enrollment target is 77 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03467009, a NA study, has completed, sponsored by Rhode Island Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 77 participants
- Enrollment target
Study Summary
The purpose of this randomized controlled study is to evaluate acceptability and feasibility, and to gather preliminary data about efficacy, of "iPACT" (intervention to Prevent Adolescent Cyber-victimization with Text messages), a brief in-clinic introductory session + longitudinal automated text-message-based secondary prevention program for adolescents with a history of past-year cyber-victimization presenting to a pediatric clinic for well-child visits.
Primary Outcome
Enrollment Rate: % of eligible participants who consented and completed enrollment
Interventions
- BEHAVIORAL iPACT Intervention
- OTHER Control: Enhanced Usual Care (EUC)
- BEHAVIORAL iPACT Intervention- app
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2018-03-06 |
| Est. Completion | 2019-07-31 |
| Phase | NA |
What the finished NCT03467009 record still lists
NCT03467009 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 77 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 3 interventions - of which iPACT Intervention is the first listed.
NCT03467009 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03467009 about?
NCT03467009 is a clinical study titled "Bullying Prevention Intervention for Adolescent Primary Care Patients". The purpose of this randomized controlled study is to evaluate acceptability and feasibility, and to gather preliminary data about efficacy, of "iPACT" (intervention to Prevent Adolescent Cyber-victimization with Text messages), a brief in-clinic introductory session + longitudinal automated text-me...
What is the current status of trial NCT03467009?
This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2018-03-06. Estimated completion is 2019-07-31.
What interventions are being tested in trial NCT03467009?
The interventions under investigation include: iPACT Intervention (BEHAVIORAL), Control: Enhanced Usual Care (EUC) (OTHER), iPACT Intervention- app (BEHAVIORAL).
Who is sponsoring clinical trial NCT03467009?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03467009's enrollment target sits among peer trials
77 1062nd of 2000 higher than 939 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02127398 · 77 participants · Phase 2
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
- NCT04159103 · 77 participants · Phase 1
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- NCT04683003 · 77 participants · Phase 3
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
- NCT05004116 · 77 participants · Phase 1
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI